This company listing is no longer active
Atreca Beheer
Beheer criteriumcontroles 3/4
Atreca's CEO is John Orwin, appointed in Apr 2018, has a tenure of 6.17 years. total yearly compensation is $927.03K, comprised of 64.8% salary and 35.2% bonuses, including company stock and options. directly owns 0.2% of the company’s shares, worth €3.37K. The average tenure of the management team and the board of directors is 5 years and 5.5 years respectively.
Belangrijke informatie
John Orwin
Algemeen directeur
US$927.0k
Totale compensatie
| Percentage CEO-salaris | 64.8% |
| Dienstverband CEO | 6.2yrs |
| Eigendom CEO | 0.2% |
| Management gemiddelde ambtstermijn | 5yrs |
| Gemiddelde ambtstermijn bestuur | 5.5yrs |
Recente managementupdates
Recent updates
Analyse CEO-vergoeding
| Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
|---|---|---|---|
| Sep 30 2023 | n/a | n/a | -US$98m |
| Jun 30 2023 | n/a | n/a | -US$85m |
| Mar 31 2023 | n/a | n/a | -US$93m |
| Dec 31 2022 | US$927k | US$601k | -US$97m |
| Sep 30 2022 | n/a | n/a | -US$105m |
| Jun 30 2022 | n/a | n/a | -US$110m |
| Mar 31 2022 | n/a | n/a | -US$108m |
| Dec 31 2021 | US$4m | US$583k | -US$109m |
| Sep 30 2021 | n/a | n/a | -US$103m |
| Jun 30 2021 | n/a | n/a | -US$98m |
| Mar 31 2021 | n/a | n/a | -US$92m |
| Dec 31 2020 | US$5m | US$567k | -US$86m |
| Sep 30 2020 | n/a | n/a | -US$83m |
| Jun 30 2020 | n/a | n/a | -US$76m |
| Mar 31 2020 | n/a | n/a | -US$74m |
| Dec 31 2019 | US$845k | US$507k | -US$67m |
| Sep 30 2019 | n/a | n/a | -US$59m |
| Jun 30 2019 | n/a | n/a | -US$53m |
| Mar 31 2019 | n/a | n/a | -US$44m |
| Dec 31 2018 | US$5m | US$319k | -US$38m |
Compensatie versus markt: John's total compensation ($USD927.03K) is above average for companies of similar size in the German market ($USD434.04K).
Compensatie versus inkomsten: John's compensation has been consistent with company performance over the past year.
CEO
John Orwin (59 yo)
6.2yrs
Tenure
US$927,033
Compensatie
Mr. John A. Orwin, M.B.A. serves as Chairman of the Board for Nested Therapeutics since February 2024. He serves as Independent Chairman of the Board of AnaptysBio, Inc. since September 15, 2023. He has be...
Leiderschapsteam
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| President | 6.2yrs | US$927.03k | 0.20% € 3.4k | |
| Founder & Director | no data | US$665.50k | 0.81% € 14.0k | |
| Principal Accounting Officer | less than a year | geen gegevens | geen gegevens | |
| General Counsel & Corporate Secretary | 5yrs | geen gegevens | 0.073% € 1.3k | |
| Vice President of Finance | no data | geen gegevens | 0.067% € 1.2k |
5.0yrs
Gemiddelde duur
59.5yo
Gemiddelde leeftijd
Ervaren management: 0C1's management team is seasoned and experienced (5 years average tenure).
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| President | 6.2yrs | US$927.03k | 0.20% € 3.4k | |
| Founder & Director | 14.4yrs | US$665.50k | 0.81% € 14.0k | |
| Independent Chairman of the Board | 10.5yrs | US$97.77k | 0.13% € 2.2k | |
| Chairman of External Scientific Advisory Board & Technical Advisor | 4.8yrs | US$150.00k | geen gegevens | |
| Independent Director | 4.1yrs | US$64.27k | 0% € 0 | |
| Director | 13.4yrs | US$312.77k | 0.93% € 16.0k | |
| Independent Director | 8.1yrs | US$70.77k | 0% € 0 | |
| Independent Director | 2.9yrs | US$60.27k | 0% € 0 | |
| Board Observer | no data | geen gegevens | geen gegevens | |
| Board Observer | no data | geen gegevens | geen gegevens | |
| Independent Director | 4.8yrs | US$62.77k | 0% € 0 | |
| Independent Director | 2.9yrs | US$57.77k | 0% € 0 |
5.5yrs
Gemiddelde duur
57.5yo
Gemiddelde leeftijd
Ervaren bestuur: 0C1's board of directors are considered experienced (5.5 years average tenure).